Iatrogenic Cushing Syndrome in a 47-Year-Old HIV-Positive Woman on Ritonavir and Inhaled Budesonide
Iatrogenic Cushing syndrome (CS) is a well-known complication of treating patients with systemic steroids. More rarely, it has been described in HIV-positive patients on ritonavir (RTV) while using the inhaled corticosteroid fluticasone, which is metabolized through the cytochrome P450 3A4 (CYP3A4)...
Main Authors: | Lily Colpitts MD, Thomas B. Murray MD, Sami G. Tahhan MD, FACP, Jody P. Boggs MD, FACP |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-11-01
|
Series: | Journal of the International Association of Providers of AIDS Care |
Online Access: | https://doi.org/10.1177/2325957417736612 |
Similar Items
-
Rapid Development of Iatrogenic Cushing Syndrome In A Patient On Ritonavir: The Adverse Metabolic Consequence of Topical Steroid Use
by: Jeremy D. Purser, MD, et al.
Published: (2020-11-01) -
Iatrogenic Cushing’s syndrome and Secondary Adrenal Insufficiency in an HIV Patientreceiving Fluticasone and Ritonavir
by: Imro Vlasveld, et al.
Published: (2014-04-01) -
Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review
by: Sapna Sadarangani, et al.
Published: (2014-01-01) -
Iatrogenic Cushing’s syndrome with inhaled steroid plus antidepressant drugs
by: Celik Ozlem, et al.
Published: (2012-08-01) -
Comparison of 12-Week Additional Effect Features of Formoterol Co-Inhalation and Tulobuterol Patch on Budesonide Inhalation in Elderly Patients With Asthma
by: Susumu Fukahori MD, PhD, et al.
Published: (2020-12-01)